| 000 | 01697 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516133541.0 | ||
| 264 | 0 | _c20130722 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1873-376X | ||
| 024 | 7 |
_a10.1016/j.jchromb.2012.12.028 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJourdil, Jean-François | |
| 245 | 0 | 0 |
_aSimultaneous quantitation of azole antifungals, antibiotics, imatinib, and raltegravir in human plasma by two-dimensional high-performance liquid chromatography-tandem mass spectrometry. _h[electronic resource] |
| 260 |
_bJournal of chromatography. B, Analytical technologies in the biomedical and life sciences _cMar 2013 |
||
| 300 |
_a1-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xblood |
| 650 | 0 | 4 |
_aAntifungal Agents _xblood |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xblood |
| 650 | 0 | 4 |
_aAzoles _xblood |
| 650 | 0 | 4 |
_aBenzamides _xblood |
| 650 | 0 | 4 |
_aChromatography, High Pressure Liquid _xmethods |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 | _aLeast-Squares Analysis |
| 650 | 0 | 4 | _aLimit of Detection |
| 650 | 0 | 4 |
_aPiperazines _xblood |
| 650 | 0 | 4 |
_aPyrimidines _xblood |
| 650 | 0 | 4 |
_aPyrrolidinones _xblood |
| 650 | 0 | 4 | _aRaltegravir Potassium |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aTandem Mass Spectrometry _xmethods |
| 700 | 1 | _aTonini, Julia | |
| 700 | 1 | _aStanke-Labesque, Françoise | |
| 773 | 0 |
_tJournal of chromatography. B, Analytical technologies in the biomedical and life sciences _gvol. 919-920 _gp. 1-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jchromb.2012.12.028 _zAvailable from publisher's website |
| 999 |
_c22480543 _d22480543 |
||